Literature DB >> 10938089

The paired homeodomain transcription factor Pax-2 is expressed in the endocrine pancreas and transactivates the glucagon gene promoter.

B Ritz-Laser1, A Estreicher, B Gauthier, J Philippe.   

Abstract

Glucagon gene expression is controlled by at least four DNA elements within the promoter; G2, G3, and G4 confer islet-specific expression, while G1 restricts glucagon transcription to alpha cells. Two islet-specific complexes are formed on G3, the insulin-responsive element of the glucagon gene; one of these corresponds to the paired homeodomain protein Pax-6, a major glucagon gene transactivator that plays a crucial role in alpha cell development. We describe here the identification of the second complex as Pax-2, another member of the paired box family. Pax-2 is known to be crucial for the development of the urogenital tract and of the central nervous system, but its presence in the endocrine pancreas has not been reported. We detected Pax-2 gene expression by RT-PCR; in islets, Pax-2 is present as two alternative splicing isoforms, Pax-2A and Pax-2B, whereas in the glucagon- and insulin-producing cell lines alphaTC1 and Min6, a distinct isoform, Pax-2D2, is found in addition to Pax-2B. Both islet-specific isoforms bind to the enhancer element G3 and to the alpha-specific promoter element G1 that also interacts with Pax-6. Pax-2A and Pax-2B dose-dependently activate transcription from the G3 and the G1 elements both in heterologous and in glucagon-producing cells. Our data indicate that Pax-2 is the third paired domain protein present in the endocrine pancreas and that one of its roles may be the regulation of glucagon gene expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938089     DOI: 10.1074/jbc.M005704200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

2.  The evolution of alternative splicing in the Pax family: the view from the Basal chordate amphioxus.

Authors:  Stephen Short; Linda Z Holland
Journal:  J Mol Evol       Date:  2008-05-14       Impact factor: 2.395

3.  Tumor suppressor menin represses paired box gene 2 expression via Wilms tumor suppressor protein-polycomb group complex.

Authors:  Bin Xu; De-quan Zeng; Yuan Wu; Rong Zheng; Le Gu; Xiao Lin; Xianxin Hua; Guang-Hui Jin
Journal:  J Biol Chem       Date:  2011-03-04       Impact factor: 5.157

4.  Research resource: the pdx1 cistrome of pancreatic islets.

Authors:  Cynthia Khoo; Juxiang Yang; Samuel A Weinrott; Klaus H Kaestner; Ali Naji; Jonathan Schug; Doris A Stoffers
Journal:  Mol Endocrinol       Date:  2012-02-09

Review 5.  Overview of PAX gene family: analysis of human tissue-specific variant expression and involvement in human disease.

Authors:  Brian Thompson; Emily A Davidson; Wei Liu; Daniel W Nebert; Elspeth A Bruford; Hongyu Zhao; Emmanouil T Dermitzakis; David C Thompson; Vasilis Vasiliou
Journal:  Hum Genet       Date:  2020-07-29       Impact factor: 4.132

6.  Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors.

Authors:  Petra I Lorenzo; Carmen M Jimenez Moreno; Irene Delgado; Nadia Cobo-Vuilleumier; Raphael Meier; Lourdes Gomez-Izquierdo; Thierry Berney; Rocio Garcia-Carbonero; Anabel Rojas; Benoit R Gauthier
Journal:  Histochem Cell Biol       Date:  2011-09-20       Impact factor: 4.304

7.  PAX Genes in Cancer; Friends or Foes?

Authors:  Caiyun G Li; Michael R Eccles
Journal:  Front Genet       Date:  2012-01-31       Impact factor: 4.599

8.  PAX2 Expression in Ovarian Cancer.

Authors:  Huijuan Song; Suet-Yan Kwan; Daisy I Izaguirre; Zhifei Zu; Yvonne T Tsang; Celestine S Tung; Erin R King; Samuel C Mok; David M Gershenson; Kwong-Kwok Wong
Journal:  Int J Mol Sci       Date:  2013-03-15       Impact factor: 5.923

9.  IRS1 gene variants, dysglycaemic metabolic changes and type-2 diabetes risk.

Authors:  N Yiannakouris; J A Cooper; S Shah; F Drenos; H A Ireland; J W Stephens; K-W Li; R Elkeles; I F Godsland; M Kivimaki; A D Hingorani; M Kumari; P J Talmud; S E Humphries
Journal:  Nutr Metab Cardiovasc Dis       Date:  2011-09-14       Impact factor: 4.222

10.  Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer?

Authors:  Anna Markowska; Monika Pawałowska; Violetta Filas; Konstanty Korski; Marian Gryboś; Stefan Sajdak; Anita Olejek; Wiesława Bednarek; Beata Spiewankiewicz; Jolanta Lubin; Janina Markowska
Journal:  Diabetol Metab Syndr       Date:  2013-12-05       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.